I

ICON | Salt Lake City, UT

Research site

(Unclaimed)

Location

1255 East 3900 South, Salt Lake City, Utah, United States of America

Site insights

Top conditions

Top treatments

LY3985297

TAK-951

TAK-781

LY3537982

LY4088044

GS-4571

Donepezil

Quinidine

Orforglipron

MK-1942-005

Parent organization

This site is a part of ICON

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 15 total trials

A Study of LY4088044 in Healthy Participants

The purpose of this study is to evaluate how well LY4088044 is tolerated and what side effects may occur in healthy participants. The study drug will...

Enrolling

Healthy

Drug: LY4088044

Drug: Placebo

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy p...

Enrolling

Healthy

Drug: Olomorasib

A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

The main aim of this study is to see if the drug TAK-781 is safe for healthy volunteers and for participants with PSC. The study will also look at ho...

Begins enrollment in 1 month

Primary Sclerosing Cholangitis

Healthy Volunteers

Drug: TAK-781

Drug: Placebo

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

The goal of this clinical study is to learn more about the study drug, GS-4571, and how safe it is in 3 groups, i) Healthy participants, ii) Healthy...

Enrolling

Weight Management

Drug: Omeprazole

Drug: Placebo